Review
Copyright ©The Author(s) 2015.
World J Transplant. Dec 24, 2015; 5(4): 154-164
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.154
Table 1 Comparison of select preservation solutions
Euro-CollinsUniversity of WisconsinHistidine-tryptophan-ketoglutarateCelsior
Intracellular/extracellularIntracellularIntracellularExtracellularExtracellular
Sodium102515100
Potassium1151201015
ImpermeantGlucoseLactobionateMannitolLactobionate
MannitolRaffinoseMannitol
Hydroxyethyl starch
BufferPhosphatePhosphateHistidineHistidine
Bicarbonate
AntioxidantMannitolAllopurinolTryptophanGlutathione
glutathioneMannitolMannitol
HistidineHistidine
Energy precursor---AdenosineGlutamic acid/glutamateGlutamic acid/glutamate
OthersInsulinKetoglutarate
Dexamethasone
Table 2 Selected clinical studies involving liver preservation solutions
Ref.SolutionCasesPatient survivalGraft survival
UW vs HTK
Erhard et al[43]UW vs HTK60 (UW 30, HTK 30)No diff (30 mo)No diff (3 mo)
(UW 74%, HTK 77%)(UW 80%, HTK 87%)
Mangus et al[44]UW vs HTK378 (UW 204, HTK 174)No diff (1 yr)No diff (1 yr)
(UW 84.6%, HTK 82.1%)(UW 81.7%, HTK 80.8%)
Rayya et al[45]UW vs HTK137 (UW 68, HTK 69)No diff (1 yr)No diff (1 yr)
(UW 78%, HTK 78%)(UW 78%, HTK 71%)
Mangus et al[51]UW vs HTK698 (UW 327, HTK 371)No diff (1 yr)No diff (1 yr)
(UW 88%, HTK 87%)(UW 84%, HTK 86%)
Avolio et al[46]UW vs HTK39 (UW 22, HTK 17)No diff (not stated)No diff (6 mo)
(UW 82%, HTK 88%)(UW 80.9%, HTK 85.7%)
Canelo et al[47]UW vs HTK134 (UW 71, HTK 63)No diffNo diff
Celsior vs (HTK or UW)
Nardo et al[57]CEL vs HTK40 (CEL 20, HTK 20)No diff (1 yr)No diff (1 yr)
(CEL 90%, HTK 85%)(CEL 90%, HTK 75%)
García-Gil et al[56]CEL vs UW80 (CEL 40, UW 40)No diff (1 yr)No diff (1 yr)
(CEL 85.7%, UW 79.8%)(CEL 78%, UW 75.5%)
Cavallari et al[55]CEL vs UW173 (CEL 83, UW 90)No diff (1 yr)No diff (1 yr)
(CEL 87%, UW 89%)(CEL 85%, UW 83%)
Lopez-Andujar et al[53]CEL vs UW196 (CEL 92, UW 104)No diff (1 yr)No diff (1 yr)
(CEL 83%, UW 83%)(CEL 81%, UW 80%)
Pedotti et al[54]CEL vs UW175 (CEL 79, UW 96)No diff (1 yr)No diff (1 yr)
(CEL 89.9%, UW 90.6%)(CEL 83.3%, UW 85.4%)
Table 3 Selected clinical studies involving renal preservation solutions
Ref.SolutionCasesPatient survivalGraft survival
UW solution vs HTK solution
Lynch et al[60]UW vs HTKLiving donor = 950 (UW 475, HTK 475)No diff (1 yr)No diff (1 yr)
Deceased donor = 634(living or deceased donors)(Living or deceased donors)
(UW 317, HTK 317)
de Boer et al[61]UW vs HTK611 (UW 297, HTK 314)----No diff (1 yr)
(UW 81%, HTK 83%)
Klaus et al[62]UW vs HTK51 (UW 27, HTK 24)No diff (1 yr)No diff (1 yr)
(UW 84% vs HTK 86%)(UW 78%, HTK 79%)
UW solution vs CEL solution
Montalti et al[64]UW vs CEL50 (UW 25, CEL 25)No diff (1 yr)No diff (1 yr)
(UW 100%, CEL 100%)(UW 96%, CEL 91.8%)
P value not stated
Faenza et al[23]UW vs CEL187 (UW 88, CEL 99)No diff (2 yr)No diff (2 yr)
(UW 100%, CEL 100%)(UW 75%, CEL 84%)
P value not stated
Pedotti et al[54]UW vs CEL441 (UW 269, CEL 172)No diff (1 yr)No diff (1 yr)
(UW 97.7%, CEL 99.4%)(UW 91%, CEL 94.2%)
P value not statedP value not stated
EC solution vs HTK solutions
de Boer et al[61]EC vs HTK569 (EC 277, HTK 292)----No diff (1 yr)
(EC 78%, HTK 80%)
P value not stated
Table 4 Selected clinical studies involving pancreas preservation solutions
Ref.SolutionCasesPatient survivalGraft survival
UW solution vs HTK solution
Potdar et al[68]UW vs HTK33 (UW 17, HTK 16)No diff (30 d)No diff (30 d)
(UW 100%, HTK 100%)(UW 100%, HTK 94%)
Englesbe et al[69]UW vs HTK75 (UW 41, HTK 36)No diff (90 d)No diff (90 d)
(UW 100%, HTK 100%)(UW 90.2%, HTK 86%)
Schneeberger et al[70]UW vs HTK68 (UW 41, HTK 27)No diff (6 mo)No diff (6 mo)
(100% UW and HTK 96.3%)(90.2% UW, 85.2% HTK)
Becker et al[71]UW vs HTK95 (UW 47, HTK 48)No diff (1 yr)No diff (1 yr)
(UW 89.4% and HTK 95.7%)(UW 82.6%, HTK 85.4%)
Agarwal et al[72]UW vs HTK87 (UW 10, HTK 78)No diff (1 yr)No diff (1 yr)
(UW 100% and HTK 93%)(UW 100% and HTK 92%)
Alonso et al[74]UW vs HTK97 (UW 81, HTK 16)No diff (3 yr)No diff (3 yr)
UW solution vs CEL solution
Manrique et al[77]UW vs CEL72 (UW 44, HTK 28)No diff (2 yr)No diff (2 yr)
(UW 94.7%, CEL 84.4%)(UW 74.6%, CEL 77.4%)
Boggi et al[25]UW vs CEL100 (UW 50, HTK 50)No diff (1 yr)No diff (1 yr)
(UW 98.0%, CEL 98.0%)(UW 95.8%, CEL 95.9%)